Todd Harris, Head of Corporate Development at Sienna Biopharmaceuticals, Inc. (SNNA), sold 8,210 shares at $20.00 ($164K) on 2018-04-09, disclosed to the SEC on 2018-04-09.
Open-market sale of $164k SNNA by Head of Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 5,386 | $108K | 65.6% |
| 2 | $20.00 | 2,824 | $56K | 34.4% |
| Total | $20.00 avg | 8,210 | $164K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |